Plus de 40 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century (EU-ToxRisk)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2021,
The vision of EU-ToxRisk is to drive a paradigm shift in toxicology towards an animal-free, mechanism-based integrated approach to chemical safety assessment. The project will unite all relevant disciplines and stakeholders to establish: i) pragmatic, solid read-across procedures incorporating mechanistic and toxicokinetic knowledge; and ii) ab initio hazard and risk assessment strategies of chemi ...
Voir le projet
43
Participants partenaires
TERMINÉ
Collective effects and optomechanics in ultra-cold matter (ColOpt)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
The network “Collective effects and optomechanics in ultra-cold matter” (ColOpt) will train early-stage researchers (ESR) in fundamental science and applications in the areas of cold atom and quantum physics, optical technologies and complexity science to promote European competiveness in emergent quantum technologies. It consists of nine academic nodes and three companies from six European countr ...
Voir le projet
13
Participants partenaires
TERMINÉ
European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates (EHVA)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2020,
Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. There is an urgent need to develop better vaccines and tools predictive of immunogenicity and of correlates of protection at early stage of vaccine development to mitigate the risks of failure. To address these complex and challenging scientific issues, the Eur ...
Voir le projet
43
Participants partenaires
TERMINÉ
An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment (in3)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
All chemicals whether they are drugs, cosmetics, agrochemicals or others need to be tested for their safety to man and the environment. The use of whole animal studies for the prediction of adverse effects in man, is problematic due to species dependent effects, high costs and a large burden to animals in terms of numbers and suffering. While there have been major improvements in human in vitro a ...
Voir le projet
14
Participants partenaires
TERMINÉ
The artificial pancreas in children aged 1 to 7 years with type 1 diabetes (KidsAP)
Date du début: 1 janv. 2017, Date de fin: 30 juin 2020,
TYPE 1 DIABETES is one of the most COMMON CHRONIC diseases in children with a RAPID increase in number of cases particularly in young children. Type 1 diabetes is associated with LIFE-LONG dependency on insulin administration. POOR glucose control leads to diabetes COMPLICATIONS, e.g. eye, heart, kidney disease, including BRAIN changes in young children. Episodes of VERY LOW glucose levels may be ...
Voir le projet
14
Participants partenaires
TERMINÉ
Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone (FAIR-PARK-II)
Date du début: 1 mai 2015, Date de fin: 30 avr. 2020,
Parkinson’s disease (PD) is a major, chronic, non-communicable disease and the 2nd most frequent neurodegenerative disorder worldwide. Excess iron is primarily detected in the substantia nigra pars compacta, where dopaminergic neurons are exposed to high levels of oxidative stress produced by mitochondrial disorders and dopamine metabolism. Our previous preclinical, translational and pilot clinica ...
Voir le projet
17
Participants partenaires
TERMINÉ
Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time (MDS-RIGHT)
Date du début: 1 mai 2015, Date de fin: 30 avr. 2020,
Myelodysplastic syndromes (MDS) are chronic bone marrow malignancies of the elderly, complicated by severe anaemia. MDS significantly affects quality-adjusted survival and it imposes an increasing financial burden on patients and healthcare (HC) systems. The burden of disease is expected to worsen in the future, given the aging EU population and newly identified MDS cases among those diagnosed wit ...
Voir le projet
16
Participants partenaires
TERMINÉ
Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach (BrainMatTrain)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
BrainMatTrain focuses on a comprehensive understanding of Parkinson’s disease (PD), from basics to translation, fully supported by 8 full partners partner organisation (4 research institutions, 2 hospitals, 2 SMEs) and one partner organisation (SME specialist in device design). This ETN will educate and train 15 Earlty Stage Researchers (ESRs) in functioanlised biomaterials, materials science, fun ...
Voir le projet
8
Participants partenaires
TERMINÉ
OpenRiskNet: Open e-Infrastructure to Support Data Sharing, Knowledge Integration and in silico Analysis and Modelling in Risk Assessment (OpenRiskNet)
Date du début: 1 déc. 2016, Date de fin: 30 nov. 2019,
Toxicology and risk assessment are undergoing a paradigm shift, from a phenomenological to a mechanistic discipline based on in vitro and in silico approaches that represent an important alternative to classical animal testing applied to the evaluation of chronic and systemic toxicity risks. Large databases and highly sophisticated methods, algorithms and tools are available for different tasks su ...
Voir le projet
14
Participants partenaires
TERMINÉ
Training Network for the Immunotherapy of Cancer (IMMUTRAIN)
Date du début: 1 déc. 2015, Date de fin: 30 nov. 2019,
In the European Union, cancer is the leading cause of death and the overall cancer incidence is still increasing. As a result of expanding efforts to improve cancer outcome, a main paradigm change is occurring in cancer therapy towards individualized medicine. Antibody-based therapies form an integral and constantly growing part of this approach. Antibody-based therapies will strongly influence th ...
Voir le projet
9
Participants partenaires
TERMINÉ
From Omics to Patient: Improving Diagnostics of Pathogenic Yeasts (OPATHY)
Date du début: 1 sept. 2015, Date de fin: 31 août 2019,
OPATHY is an innovative translational research training network that will explore the potential of omics technologies, including genomics, transcriptomics and proteomics, to study the interactions of yeasts that cause disease to humans (e.g. Candida and Cryptococcus sp.) with their host, and to develop new diagnostic tools to monitor yeast infections in the clinic. Today, these infections are poor ...
Voir le projet
10
Participants partenaires
TERMINÉ
Recognition and Enrichment of Archival Documents (READ)
Date du début: 1 janv. 2016, Date de fin: 30 juin 2019,
"The overall objective of READ is to implement a Virtual Research Environment where archivists, humanities scholars, computer scientists and volunteers are collaborating with the ultimate goal of boosting research, innovation, development and usage of cutting edge technology for the automated recognition, transcription, indexing and enrichment of handwritten archival documents. This Virtual Resear ...
Voir le projet
15
Participants partenaires
TERMINÉ
A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer (GANNET53)
Date du début: 1 oct. 2013, Date de fin: 31 mars 2019,
...s multicentre clinical trial and assess our innovative therapeutic concept in this deadly disease. Our consortium consists of national clinical trial groups in gynaecological oncology and high-volume University centres as well as noted p53 scientists and 3 innovative SMEs. Since ovarian cancer is defined as a rare cancer a scale at the European level is crucial for the planned clinical trial."
Voir le projet
20
Participants partenaires
TERMINÉ
Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies (DISCHARGE)
Date du début: 1 févr. 2014, Date de fin: 31 janv. 2019,
Coronary artery disease (CAD) is the leading cause of death in high-income countries. Invasive coronary angiography (ICA) is the reference standard for the diagnosis of CAD and allows immediate therapy. However, only 40% of patients undergoing ICA actually have obstructive CAD and ICA has relatively rare but considerable risks. Coronary computed tomography (CT) is the most accurate diagnostic test ...
Voir le projet
38
Participants partenaires
TERMINÉ
Health Care Work Exchange 2016
Date du début: 1 juin 2016, Date de fin: 31 mai 2018,
...nistered by the EU Liaison Office (EU-Hochschulbüro Hannover/ Hildesheim) at the Leibniz Universität Hannover. Meanwhile more than a hundred partner organizations throughout Europe, such as university teaching hospitals, private medical practices, rehabilitation centers, public and private hospitals and clinics offer such Erasmus+ internships. In addition, numerous educational institutions offer t ...
Voir le projet
39
Participants partenaires
TERMINÉ
Human Brain Project Specific Grant Agreement 1 (HBP SGA1)
Date du début: 1 avr. 2016, Date de fin: 31 mars 2018,
Understanding the human brain is one of the greatest scientific challenges of our time. Such an understanding can provide profound insights into our humanity, leading to fundamentally new computing technologies, and transforming the diagnosis and treatment of brain disorders. Modern ICT brings this prospect within reach. The HBP Flagship Initiative (HBP) thus proposes a unique strategy that uses I ...
Voir le projet
126
Participants partenaires
TERMINÉ
Rydberg Quantum Simulators (RYSQ)
Date du début: 1 mars 2015, Date de fin: 28 févr. 2018,
Quantum Simulators provide new levels of understanding of equilibrium and out-of-equilibrium properties of many-body quantum systems, one of the most challenging problems in physics. The main objective of the RYSQ project is to use Rydberg atoms for quantum simulations, because their outstanding versatility will allow us to perform a great variety of useful quantum simulations, by exploiting diffe ...
Voir le projet
16
Participants partenaires
TERMINÉ
European Clinical Research Infrastructures Network - Integrating Activity (ECRIN-IA)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2017,
ECRIN is a distributed ESFRI-roadmap pan-European infrastructure designed to support multinational clinical research, making Europe a single area for clinical studies, taking advantage of its population size to access patients. Servicing multinational trials started during its preparatory phase, and it now applies for an ERIC status by 2011. The ERIC budget will be restricted to core activities re ...
Voir le projet
48
Participants partenaires
TERMINÉ
Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its progression to disability and general consequences to health and well-being - The FRAILOMIC Initiative (FRAILOMIC)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2017,
The forecasted increase in the number of older people for this century will be accompanied by an increase of those with disabilities. Disability is usually preceded by a condition named frailty that encompasses changes associated with ageing, life styles and chronic diseases. To detect and intervene on it is of outstanding importance to prevent disability, as recovery from disability is unlikely. ...
Voir le projet
29
Participants partenaires
TERMINÉ
Cold Molecular Ions at the Quantum Limit (COMIQ)
Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,
"COMIQ (COld Molecular Ions at the Quantum limit)will investigate how cooling, trapping, and control techniques applied molecular ion can expand the realm of quantum technology, enhance precision meaurements on molecular systems and lead to chemistry at the ultracold quantum limit."
Voir le projet
10
Participants partenaires
TERMINÉ
Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC) (STEMBANCC)
Date du début: 1 oct. 2012, Date de fin: 30 sept. 2017,
StemBANCC, comprising internationally renowned investigators, is ideally positioned to deliver a unique European biorepository and drug discovery pipeline based upon human induced pluripotent stem cells (hiPSC). This unrivalled opportunity will address the pressing therapeutic need in neurodegeneration, neurodysfunction and diabetes. We have immediate access to richly phenotyped subjects with a we ...
Voir le projet
38
Participants partenaires
TERMINÉ
Non-coding RNAs in neurogenic and neuropathic pain mechanisms and their application for risk assessment, patient stratification and personalised pain medicine (NCRNAPAIN)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
Neuro-immune alterations in the peripheral and central nervous system play a role in the pathophysiology of chronic pain, and non-coding RNAs (ncRNAs) regulate both immune and neuronal processes. Therefore, ncRNAPain proposes that ncRNAs are critically important master switches for chronic pain.ncRNAPain represents a multidisciplinary consortium of clinical partners, molecular and systems-level n ...
Voir le projet
12
Participants partenaires
TERMINÉ
International Learning Platform for Accountancy
Date du début: 1 sept. 2014, Date de fin: 31 août 2017,
...r Accountancy (ILPA)”. Accountancy includes Financial Reporting, Auditing of Financial Statements, Financial Statement Analysis and Corporate Social Responsibility (CSR) Reporting.
Graduates of a University or Business School with a specialisation in accountancy do need specific competence (knowledge, skills, values, ethics and attitudes). This competence cannot be acquired effectively through a d ...
Voir le projet
10
Participants partenaires
TERMINÉ
VitaminD3-Omega3-Home Exercise- HeALTHy Ageing and Longevity Trial (DO-HEALTH)
Date du début: 1 janv. 2012, Date de fin: 30 juin 2017,
As the European population is ageing rapidly, the growing number of seniors with age-related chronic diseases poses a challenge on European societies and health care systems. Therapeutic interventions that are effective, affordable and well-tolerated in the prevention of chronic disease are urgently needed and will have an outstanding impact on public health as a whole. Among the most promising in ...
Voir le projet
25
Participants partenaires
TERMINÉ
Health Care Work Exchange 2015
Date du début: 1 juin 2015, Date de fin: 31 mai 2017,
...ect that meets students’ needs for high-quality and technically challenging internships abroad. In addition, more than 100 partner organizations throughout Europe participate in this project. University teaching hospitals, private medical practices, rehabilitation centers, public and private hospitals and clinics offer internships and a variety of educational institutions assist as intermediary pa ...
Voir le projet
38
Participants partenaires
TERMINÉ
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk (ABIRISK)
Date du début: 1 mars 2012, Date de fin: 28 févr. 2017,
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recru ...
Voir le projet
39
Participants partenaires
TERMINÉ
MOBILISING THE POTENTIAL OF ACTIVE AGEING IN EUROPE (MOPACT)
Date du début: 1 mars 2013, Date de fin: 28 févr. 2017,
The starting point for MOPACT is the ambitious goals set by Horizon 2020 and the European Innovation Partnership Pilot Project on Active and Healthy Ageing (EIPAHA). Our response is ambitious too: we aim to provide the research and practical evidence upon which Europe can make longevity an asset for social and economic development. MOPACT will create a high quality, multi-disciplinary critical mas ...
Voir le projet
32
Participants partenaires
TERMINÉ
European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke (EuroHYP-1)
Date du début: 1 févr. 2012, Date de fin: 31 janv. 2017,
The consortium led by UKER and EuroHYP, the European Stroke Research Network for Hypothermia, proposes a large, multicentre clinical trial which will assess mild hypothermia as a novel treatment for ischemic stroke.Stroke is the second cause of death world-wide and the second cause of lost disability-adjusted life years in high-income countries. Stroke incidence rises exponentially with age, so it ...
Voir le projet
38
Participants partenaires
TERMINÉ
EUROPEAN FORENSIC GENETICS Network of Excellence (EUROFORGEN-NOE)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2016,
The EUROFORGEN-NoE proposal aims to develop a network of excellence for the creation of a European Virtual Centre of Forensic Genetic Research. Forensic genetics is a highly innovative field of applied science with a strong impact on the security of citizens. However, the genetic methods to identify offenders as well as the creation of national DNA databases have caused concerns to the possible vi ...
Voir le projet
19
Participants partenaires
TERMINÉ
Mathematics and science for life (MASCIL)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,
This project aims to promote a widespread use of inquiry-based science teaching (IBST) in primary and secondary schools. Our major innovation is to connect IBST in school with the world of work making science more meaningful for young European students and motivating their interest in careers in S & T. To this end, we will run training courses in which pre- and in-service teachers will learn about ...
Voir le projet
20
Participants partenaires
TERMINÉ
The Human Brain Project (HBP)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2016,
Understanding the human brain is one of the greatest challenges facing 21st century science. If we can rise to the challenge, we can gain profound insights into what makes us human, develop new treatments for brain diseases and build revolutionary new computing technologies. Today, for the first time, modern ICT has brought these goals within sight. The goal of the Human Brain Project, part of the ...
Voir le projet
116
Participants partenaires
TERMINÉ
OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) (OPTiMiSE)
Date du début: 1 févr. 2010, Date de fin: 31 juil. 2016,
OPTiMiSE (OPtimization of Treatment and Management of Schizophrenia in Europe) will focus on two goals: optimising current treatments in Schizophrenia and explore novel therapeutic options for schizophrenia. The project intends to both address basic, but so far unanswered, questions in the treatment of schizophrenia and develop new and experimental interventions. It is expected that the project wi ...
Voir le projet
25
Participants partenaires
TERMINÉ
Demonstrating Minicare, a miniaturized biophotonics platform for fast and lab-equivalent Point-of-Care diagnostics (Lab2Go)
Date du début: 1 janv. 2014, Date de fin: 30 juin 2016,
To speed up the availability of cTnI test results (for heart attack indications), a highly integrated, biophotonics based, handheld-device is currently developped by a number of European based companies (Philips, Conworx Technology, Micro Systems Limited and Scienion AG) : Minicare. This device can be used at the patients' bed side by nurses and physicians as well as in ambulances and provides re ...
Voir le projet
10
Participants partenaires
TERMINÉ
Health Care Work Exchange 2014
Date du début: 1 juin 2014, Date de fin: 31 mai 2016,
...ect that meets students’ needs for high-quality and technically challenging internships abroad. In addition, more than 100 partner organizations throughout Europe participate in this project. University teaching hospitals, private medical practices, rehabilitation centers, public and private hospitals and clinics offer internships and a variety of educational institutions assist as intermediary pa ...
Voir le projet
27
Participants partenaires
TERMINÉ
tranScriptorium
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2015,
Description
The aim of tranScriptorium is to develop innovative, cost-effective solutions for the indexing, search and full transcription of historical handwritten document images, using modern, holistic HTR techtranScriptorium aims to develop innovative, efficient and cost-effective solutions for the indexing, search and full transcripti ...
Voir le projet
6
Participants partenaires
TERMINÉ
Future Internet Technologies for MANufacturing (FITMAN)
Date du début: 1 avr. 2013, Date de fin: 30 sept. 2015,
According to the 2010 EC Competitiveness Report, Manufacturing is still the driving force of Europe's economy, contributing over € 6553 billion in GDP and providing more than 30 million jobs. It covers more than 25 different industrial sectors, largely dominated by SMEs, and generates annually over € 1535 billion (42%) worth of value added services.The mission of the FITMAN (Future Internet Techno ...
Voir le projet
41
Participants partenaires
TERMINÉ
European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Date du début: 1 mai 2010, Date de fin: 30 avr. 2015,
EFACTS (the European Friedreich’s Ataxia Consortium for Translational Studies) assembles a body of expertise to adopt a translational research strategy for the rare autosomal recessive neurological disease, Friedreich’s ataxia (FRDA). FRDA is a severely debilitating disease that leads to loss of the ability to walk and dependency for all activities. Some patients have cardiomyopathy that can cause ...
Voir le projet
15
Participants partenaires
TERMINÉ
Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses (SILVER)
Date du début: 1 oct. 2010, Date de fin: 31 mars 2015,
RNA virus infections kill millions of humans annually, largely due to the lack of suitable vaccines and drugs to control them. This problem is addressed in this FP7 call and in response a consortium of Europe’s and Asia’s leading molecular virologists, structural biologists, medicinal chemists and bioinformaticians has been brought together to generate a state-of-the-art drug discovery and design ...
Voir le projet
25
Participants partenaires
TERMINÉ
Expanding EPNOE leadership towards Food and Health related materials, and increasing industrial participation (EPNOE CSA)
Date du début: 1 mars 2012, Date de fin: 28 févr. 2015,
The need for a transition towards a CO2 neutral biobased economy or bioeconomy, increasing population and globalisation of economies will have the consequence of a need for enhanced supplies of biobased resources. To this end, polysaccharides will be at the central point of the world of tomorrow for sustainable fuel, food, materials and medicine production. EPNOE (European Polysaccharide Network o ...
Voir le projet
18
Participants partenaires
TERMINÉ
Inflammatory Bowel Disease: an EU-NZ integrated approach for characterizing its molecular multifactorial mechanisms (REINFORCE)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2014,
"Over the past 20 years there has been a dramatic rise in the incidence of Inflammatory bowel disease (IBD), both in EU and NZ. IBD refers primarily to two major disorders such as ulcerative colitis (UC) and Crohn's disease (CD), chronic conditions characterized by inflammatory lesions involving gut mucosa. CD is also an emerging problem amongst children. Etiology of IBD is still unknown, however ...
Voir le projet